Austedo is manufactured by Teva Pharmaceuticals [1].
What is Austedo used for?
Austedo is approved for the treatment of chorea associated with Huntington's disease and tardive dyskinesia [2].
How does Austedo work?
Austedo is a brand name for deutetrabenazine. It works by affecting the amount of certain natural substances in the brain that are involved in controlling body movements [2].
When did Austedo receive FDA approval?
Austedo received its initial FDA approval in April 2017 for chorea associated with Huntington's disease. Approval for tardive dyskinesia followed in August 2019 [2].
What is the patent status for Austedo?
Information regarding the specific patent exclusivity for Austedo can be found on DrugPatentWatch.com [1]. Patents for drugs can be complex, involving multiple patents covering the active ingredient, manufacturing processes, and specific uses.
Who are Austedo's competitors?
For Huntington's disease, Austedo competes with other treatments that manage chorea. For tardive dyskinesia, it is one of the available therapeutic options [2].
What are the side effects of Austedo?
Common side effects of Austedo may include drowsiness, fatigue, insomnia, depression, anxiety, and dry mouth [2]. A significant concern with drugs affecting neurotransmitters is the potential for mood changes, including depression and suicidal thoughts [2].
Can Austedo be used by pregnant or breastfeeding individuals?
It is recommended to discuss the use of Austedo with a healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. The drug has a pregnancy registry to monitor outcomes [2].